Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Melanoma 21Breast Neoplasms 19Prostatic Neoplasms 12Neuroblastoma 11Multiple Myeloma 11Leukemia 11Leukemia, Myeloid, Acute 10Lymphoma 9Lymphoma, Non-Hodgkin 8Leukemia, Lymphocytic, Chronic, B-Cell 8Breast Neoplasms, Male 8Glioblastoma 7Ovarian Neoplasms 6Myelodysplastic Syndromes 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Fallopian Tube Neoplasms 5Colorectal Neoplasms 5Neoplasms 4Lymphoma, Follicular 4Leukemia, Myeloid, Chronic-Phase 4Hodgkin Disease 4Glioma 4Carcinoma, Ovarian Epithelial 4Uveal Melanoma 3Rhabdomyosarcoma 3Pancreatic Neoplasms 3Medulloblastoma 3Lung Neoplasms 3

Interventions

Tacrolimus 37Methotrexate 27Cyclophosphamide 27Mycophenolic Acid 21fludarabine phosphate 19Busulfan 19Antilymphocyte Serum 19Cyclosporine 18Sirolimus 16Methylprednisolone 16fludarabine 15Peripheral Blood Stem Cell Transplantation 15Melphalan 14Filgrastim 13Radiotherapy 12Whole-Body Irradiation 8Granulocyte Colony-Stimulating Factor 8thymoglobulin 6Stem Cell Transplantation 6Rituximab 6Prednisone 6Pentostatin 6Hematopoietic Stem Cell Transplantation 5Etoposide 5ruxolitinib 4Thiotepa 4Flow Cytometry 4Cytarabine 4Cyclosporins 4Cord Blood Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Graft vs Host Disease × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00429416 2016-11-29

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Thomas Jefferson University

Phase 1/2 Completed
14 enrolled 11 charts
Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT00001561 2007-09-24

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
30 enrolled
Plasma cell

Graft vs Host Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡